Response to: Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non‐Renal Systemic Lupus Erythematosus

Mia Rodziewicz; Sarah Dyball; Sheilla Achieng; Silke r Brix; Ian n Bruce; Ben Parker

doi:10.1002/art.42689

Response to: Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non‐Renal Systemic Lupus Erythematosus

Mia Rodziewicz, Sarah Dyball, Sheilla Achieng, Silke r Brix, Ian n Bruce, Ben Parker

Central Manchester University Hospitals NHS Foundation Trust

Research output: Contribution to journal › Letter › peer-review

38 Downloads (Pure)

Original language	English
Journal	Arthritis & Rheumatology (Hoboken)
Early online date	31 Aug 2023
DOIs	https://doi.org/10.1002/art.42689
Publication status	E-pub ahead of print - 31 Aug 2023

Access to Document

10.1002/art.42689Licence: Other

Arthritis Rheumatology - 2023 - Rodziewicz (2)Accepted author manuscript, 209 KBLicence: CC BY

Cite this

@article{b9574636816f4b5ea5333a19c332a011,

title = "Response to: Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non‐Renal Systemic Lupus Erythematosus",

author = "Mia Rodziewicz and Sarah Dyball and Sheilla Achieng and Brix, {Silke r} and Bruce, {Ian n} and Ben Parker",

year = "2023",

month = aug,

day = "31",

doi = "10.1002/art.42689",

language = "English",

journal = "Arthritis & Rheumatology (Hoboken)",

issn = "2326-5191",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Response to: Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non‐Renal Systemic Lupus Erythematosus

AU - Rodziewicz, Mia

AU - Dyball, Sarah

AU - Achieng, Sheilla

AU - Brix, Silke r

AU - Bruce, Ian n

AU - Parker, Ben

PY - 2023/8/31

Y1 - 2023/8/31

UR - https://research.manchester.ac.uk/en/publications/b9574636-816f-4b5e-a533-3a19c332a011

U2 - 10.1002/art.42689

DO - 10.1002/art.42689

M3 - Letter

SN - 2326-5191

JO - Arthritis & Rheumatology (Hoboken)

JF - Arthritis & Rheumatology (Hoboken)

ER -

Response to: Comparative Risks of Infection with Belimumab versus Oral Immunosuppressants in Patients with Non‐Renal Systemic Lupus Erythematosus

Access to Document

Other files and links

Cite this